Sano Genetics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $11.4M

  • Investors
  • 23

Sano Genetics General Information

Description

Developer of a genetic research platform designed to facilitate a direct connection between users and researchers. The company's platform offers research into many common disorders, such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy, enabling researchers to do research into personalized medicine and access dynamic health and genetic data sets, which could lead to new treatments and cures for diseases.

Contact Information

Formerly Known As
Heterogeneous
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, 86-90 Paul Street
  • London EC2A 4NE
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Decision/Risk Analysis
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 3rd Floor, 86-90 Paul Street
  • London EC2A 4NE
  • England, United Kingdom

Sano Genetics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sano Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 22-Jan-2024 $11.4M Completed Generating Revenue
11. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Grant 01-Jul-2022 Completed Generating Revenue
8. Later Stage VC (Series A) 10-Feb-2022 Completed Generating Revenue
7. Seed Round 25-Jan-2021 Completed Generating Revenue
6. Grant 01-Jan-2021 Completed Generating Revenue
5. Grant 01-Nov-2020 Completed Generating Revenue
4. Grant 01-Jun-2020 $61K $664K Completed Generating Revenue
3. Grant 01-Oct-2019 $295K $664K Completed Generating Revenue
To view Sano Genetics’s complete valuation and funding history, request access »

Sano Genetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B-1 Ordinary
B Ordianry
A Ordinary
Seed 468,612 $0.000127 $6.63 $6.63 1x $6.63 15.4%
A Ordinary 72,069 $0.000127 $1.76 $1.76 1x $1.76 2.37%
To view Sano Genetics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sano Genetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genetic research platform designed to facilitate a direct connection between users and researchers. The c
Biotechnology
London, United Kingdom
60 As of 2025

Seattle, WA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sano Genetics Competitors (2)

One of Sano Genetics’s 2 competitors is Phase Genomics, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phase Genomics Venture Capital-Backed Seattle, WA
Arima Genomics Venture Capital-Backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Sano Genetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sano Genetics Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Angels Angel Group Minority
Mainspring Fund Services PE-Backed Company Minority
Plural (England) Venture Capital Minority
PharmStars Accelerator/Incubator
Angel (individual) Minority
You’re viewing 5 of 23 investors. Get the full list »

Sano Genetics FAQs

  • When was Sano Genetics founded?

    Sano Genetics was founded in 2016.

  • Where is Sano Genetics headquartered?

    Sano Genetics is headquartered in London, United Kingdom.

  • What is the size of Sano Genetics?

    Sano Genetics has 60 total employees.

  • What industry is Sano Genetics in?

    Sano Genetics’s primary industry is Biotechnology.

  • Is Sano Genetics a private or public company?

    Sano Genetics is a Private company.

  • What is the current valuation of Sano Genetics?

    The current valuation of Sano Genetics is .

  • What is Sano Genetics’s current revenue?

    The current revenue for Sano Genetics is .

  • How much funding has Sano Genetics raised over time?

    Sano Genetics has raised $26.6M.

  • Who are Sano Genetics’s investors?

    Cambridge Angels, Mainspring Fund Services, Plural (England), PharmStars, and are 5 of 23 investors who have invested in Sano Genetics.

  • Who are Sano Genetics’s competitors?

    Phase Genomics and Arima Genomics are competitors of Sano Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process